Prosus tops €480 million funding round for French health‑tech firm Alan, pushing its valuation to €5.5 billion. The move ranks as one of Europe’s biggest non‑AI deals this year. Alan, founded a decade ago, has grown to more than 1.1 million members and aims to exceed €1 billion in annual recurring revenue by year‑end.

Alan’s model blends AI‑driven underwriting with corporate health‑insurance contracts for giants such as Volkswagen and the French government. Its app delivers virtual doctor visits and an AI assistant that schedules appointments and triages patients. The €480 million infuses capital to expand beyond France, leveraging Prosus’s global consumer‑platform expertise.

Existing investors, including Teachers’ Venture Growth and Index Ventures, also participated, signalling confidence in Alan’s profitability in France and its loss‑making but high‑growth trajectory for future growth. First‑quarter sales jumped 53 percent year‑on‑year to €800 million, underscoring the company’s scale and the strategic fit with Prosus’s AI‑safety agenda to all stakeholders and investors.

With the U.S. curbing access to Anthropic’s models, European firms like Alan highlight the need for sovereign AI capabilities. Prosus’s investment reinforces that narrative, positioning Alan as a leading AI‑advanced insurer poised to scale globally while protecting sensitive healthcare data.